Appili Therapeutics Overview
- Founded
- 2015
- Status
- Public
- Employees
- 13
- Stock Symbol
- APLI
- Investments
- 1
- Share Price
- $0.86
- (As of Friday Closing)
Appili Therapeutics General Information
Description
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.
Contact Information
Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
TSE
Primary Office
- 1344 Summer Street
- Suite 21
- Halifax, Nova Scotia B3H 0A8
- Canada
+1 (902) 000-0000
Appili Therapeutics Timeline
Appili Therapeutics Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.86 | $0.87 | $0.35 - $1.36 | $54.5M | 62.6M | 135K | -$0.12 |
Appili Therapeutics Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2020 | FY 2020 31-Mar-2020 | FY 2019 31-Mar-2019 | FY 2018 31-Mar-2018 |
|---|---|---|---|---|
| EV | 44,152 | 21,156 | ||
| Revenue | 148 | 150 | 0 | 0 |
| EBITDA | (5,591) | (4,049) | (3,315) | (2,921) |
| Net Income | (5,603) | (4,071) | (3,299) | (3,097) |
| Total Assets | 17,722 | 7,879 | 5,119 | 5,568 |
| Total Debt | 757 | 709 | 838 | 861 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Appili Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Appili Therapeutics‘s full profile, request access.
Request a free trialAppili Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective th
Drug Discovery
Halifax, Canada
13
As of 2020
000.00
000000000
000.00
00000000
usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exer
0000 000000000
Exton, PA
000
As of 0000
0000
0000
0000-00-00
000000&0
0000
00000 00
t esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
0000000000000
Boulder, CO
000
As of 0000
00000
00.00
0000-00-00
000000&0
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAppili Therapeutics Competitors (31)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Morphotek | Formerly VC-backed | Exton, PA | 000 | 0000 | 000000&0 | 0000 |
| 00000 000000000 | Formerly VC-backed | Boulder, CO | 000 | 00000 | 000000&0 | 00000 |
| 00000 00000 000000 | Venture Capital-Backed | Geneva, Switzerland | 00 | 00000 | 0000000000 0 | 00000 |
| 00000 000000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 000.00 | 000000 - 000 | 000.00 |
| 00000000 000000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000000 - | 00000 |
Appili Therapeutics Executive Team (9)
Appili Therapeutics Board Members (14)
| Name | Representing | Role | Since |
|---|---|---|---|
| Armand Balboni Ph.D | Appili Therapeutics | Chief Executive Officer & Board Member | 000 0000 |
| Brian Bloom | Bloom Burton & Co. | Board Member | 000 0000 |
| Ian Mortimer | Self | Chairman & Board Member | 000 0000 |
| John Holyoake Ph.D | Bloom Burton & Co. | Board Member | 000 0000 |
| Juergen Froehlich MD | Appili Therapeutics | Board Member | 000 0000 |
Appili Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAppili Therapeutics Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 00000000 (0 | 21-Nov-2019 | 000000000 00000 00 | Buildings and Property | 00000 00000000 |